X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

Fairfax Behavioral Health to open 34-bed Psychiatric Unit at Valley General Hospital State of Washington Approves Certificate of Need to Expand Psychiatric Care in Region

Yuvraj_pawp by Yuvraj_pawp
5th September 2014
in Market Moves

In a step forward to remedy a state-wide shortage of inpatient psychiatric care beds, Valley General Hospital, an affiliate of EvergreenHealth, today announced that it, together with Fairfax Behavioral Health, received approval from the state to open a 34-bed psychiatric hospital on its campus in Monroe, Washington.

 

The new psychiatric hospital is part of Valley General’s ongoing commitment to provide Snohomish County with access to high-quality care, and is slated to open in 2015.

 

“Across the state, many mental health patients are in crisis with very few options for treatment. Our collaboration with Fairfax Behavioral Health is one positive step forward to ease our state’s overburdened mental health system and help ensure that mental health patients seeking treatment for all forms of illness have access to expert care,” said Eric Jensen, CEO of Valley General Hospital.

 

Under the agreement, Fairfax Behavioral Health will own and operate the psychiatric hospital, providing Snohomish County with improved access to high-quality behavioral health care. The psychiatric hospital will provide services delivered by a multidisciplinary group of qualified professional staff including psychiatrists, nurse practitioners, registered nurses, mental health professionals, psychologists, pharmacists and registered recreational therapists.

 

“This is good news for the residents of east Snohomish County,” said Scott Bond, president and CEO of the Washington State Hospital Association. “Behavioral health services are deeply needed across the state. The establishment of a Fairfax hospital on the Valley General campus will help more people get access to high-quality, specialized care. And just as importantly, they’ll be able to get care close to home.”

 

Inpatient psychiatric hospitalization requires a highly specialized staff, and Fairfax brings a proven track record of effective psychiatric hospital management to the partnership. Fairfax has an 83-year history of service to the Northwest region, and is the largest private provider of inpatient psychiatric services in the state of Washington.

 

“Our county is in great need of additional psychiatric beds, and we saw an opportunity to bring this essential service to the region by partnering with Fairfax. Together, we are working diligently to provide this underserved population with greater access to specialized care, right in our community,” said Jensen.

 

The psychiatric hospital will be located in Valley General Hospital’s F Wing and will treat older adult patients on both a voluntary and involuntary basis. The F Wing previously housed Valley General’s geriatric psychiatric inpatient unit, which closed in 2011.

 

The agreement allows Fairfax to lease a portion of Valley General’s Monroe campus for up to 20 years. Both organizations will remain independent, and Fairfax will be the sole-operator of the psychiatric hospital for the duration of the lease.

About Valley General Hospital
Now affiliated with EvergreenHealth of Kirkland, Washington, Valley General Hospital is an accredited, full-service district hospital located in Monroe, Washington since 1960. The district includes 100,000 people in central and eastern Snohomish County, and provides primary care for community members through the Sky River Medical Group. Valley General’s mission is to serve the changing health care needs of its community. It provides personalized patient care known for quality and excellence with a healing environment through caring relationships.

SOURCE Valley General Hospital

Previous Post

Luye Pharma Acquired 57.98% Stake of Beijing Jialin Pharmaceutical

Next Post

Astellas Receives Notification from FDA of Acceptance of Filing of Isavuconazole NDA for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

Related Posts

Featured

SVB Collapse And Its Implications On Biotechnology Sector

18th March 2023
Featured

US President Looks To Double The Drugs For Price Negotiation

18th March 2023
$118bn Sales By 2026 Is What Japanese Pharma Can Expect
Featured

$118bn Sales By 2026 Is What Japanese Pharma Can Expect

2nd March 2023
Featured

Bioavailability Enhancement Market Projects CAGR of 11%

28th February 2023
Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Market Moves

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

18th July 2022
Could The Long Deckline In Biotechnology M&A Be Ending
Featured

Could The Long Deckline In Biotechnology M&A Be Ending

16th July 2022
Next Post

Astellas Receives Notification from FDA of Acceptance of Filing of Isavuconazole NDA for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In